- rms Company named first certified medical device manufacturing partner
- rms Company to receive preferred access to experts from 3D Systems and plans to exclusively use 3D Systems’ platforms for manufacturing medical implants
ROCK HILL, South Carolina, June 14, 2017 – 3D Systems (NYSE:DDD) today announced a new certified partner program for medical device additive manufacturing companies to offer secure and premium services for medical device companies. rms Company is the first to join this new quality supply network and will focus on design, development and manufacturing of medical implants using 3D Systems’ Direct Metal Printing (DMP) technology.
This first-of-its-kind partnership combines the equipment, process and materials expertise of 3D Systems with the manufacturing expertise of rms and enables medical device companies to efficiently source the development and production of FDA-cleared medical devices under one roof.
“We want customers to be able to choose among multiple partners with the same level of medical device manufacturing expertise as 3D Systems,” said Kevin McAlea, Executive Vice President, General Manager, Metals and Healthcare, 3D Systems. “With our new certified partner program and our ability to insource models for large medical device companies at our certified facilities in Denver, CO, and Leuven, Belgium, we are able to offer the same quality experience to a broader set of customers.”
As part of the new certification process, rms has validated its ProX® DMP 320 printer, the materials and critical support processes. The company is already engaged with several of its orthopedic customers to develop and manufacture implants using titanium powder.
“This partnership provides our mutual customers with access to the 3D printing, machining and secondary processing capabilities of two market leaders,” said Lee Zachman, President, rms Company. “Working together we have created a world-class service center for the manufacture of medical implants.”
Zachman continued, “With the support of our parent company, Cretex, we will have the resources to rapidly invest and grow our capacity to meet the increasing needs of our customers. The ability to print parts, add machined features and perform secondary processing in one location provides our customers with a speed to market advantage that is hard to parallel.”
More information about 3D Systems’ medical device and manufacturing business is available here.
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward looking statements can be identified by terms such as “believes,” “belief,” “expects,” “may,” “will,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations and may include comments as to the respective company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the respective company. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the respective company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as the date of the statement. Neither 3D Systems or rms Company undertakes an obligation to update or review any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise.
About 3D Systems
3D Systems provides comprehensive 3D products and services, including 3D printers, print materials, on-demand manufacturing services and digital design tools. Its ecosystem supports advanced applications from the product design shop to the factory floor to the operating room. 3D Systems’ precision healthcare capabilities include simulation, Virtual Surgical Planning, and printing of medical and dental devices as well as patient-specific surgical instruments. As the originator of 3D printing and a shaper of future 3D solutions, 3D Systems has spent its 30 year history enabling professionals and companies to optimize their designs, transform their workflows, bring innovative products to market and drive new business models.
Source: 3D Systems